Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuan Sun

Showing results (711-720 of 717) with videos related to

Pageof 72
Sort By:
You have reached the last page of results.This site can display upto 717 results.
Signal Transduction and Targeted Therapy|January 30, 2023
Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase 2/3, randomized, third-party double-blind clinical trialHuijie Bian, Liang Chen, Zhao-Hui Zheng, et al.
JAMA|July 5, 2025
Intra-arterial Tenecteplase for Acute Stroke After Successful Endovascular Therapy: The ANGEL-TNK Randomized Clinical TrialZhongrong Miao, Gang Luo, Ligang Song, et al.
Cell Metabolism|July 3, 2024
The activity of early-life gene regulatory elements is hijacked in aging through pervasive AP-1-linked chromatin openingRalph Patrick, Marina Naval-Sanchez, Nikita Deshpande, et al.
The New England Journal of Medicine|February 10, 2023
Trial of Endovascular Therapy for Acute Ischemic Stroke with Large InfarctXiaochuan Huo, Gaoting Ma, Xu Tong, et al.
Stroke|February 18, 2021
Current Status of Endovascular Treatment for Acute Large Vessel Occlusion in China: A Real-World Nationwide RegistryBaixue Jia, Zeguang Ren, Maxim Mokin, et al.
Signal Transduction and Targeted Therapy|April 13, 2025
Meplazumab, a CD147 antibody, for severe COVID-19: a double-blind, randomized, placebo-controlled, phase 3 clinical trialHuijie Bian, Liang Chen, Zheng Zhang, et al.
Signal Transduction and Targeted Therapy|May 18, 2021
Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trialHuijie Bian, Zhao-Hui Zheng, Ding Wei, et al.
Pageof 72

Showing results (711-720 of 717) with videos related to

Sort By:
Pageof 72
You have reached the last page of results.This site can display upto 717 results.
Signal Transduction and Targeted Therapy|January 30, 2023
Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase 2/3, randomized, third-party double-blind clinical trialHuijie Bian, Liang Chen, Zhao-Hui Zheng, et al.
JAMA|July 5, 2025
Intra-arterial Tenecteplase for Acute Stroke After Successful Endovascular Therapy: The ANGEL-TNK Randomized Clinical TrialZhongrong Miao, Gang Luo, Ligang Song, et al.
Cell Metabolism|July 3, 2024
The activity of early-life gene regulatory elements is hijacked in aging through pervasive AP-1-linked chromatin openingRalph Patrick, Marina Naval-Sanchez, Nikita Deshpande, et al.
The New England Journal of Medicine|February 10, 2023
Trial of Endovascular Therapy for Acute Ischemic Stroke with Large InfarctXiaochuan Huo, Gaoting Ma, Xu Tong, et al.
Stroke|February 18, 2021
Current Status of Endovascular Treatment for Acute Large Vessel Occlusion in China: A Real-World Nationwide RegistryBaixue Jia, Zeguang Ren, Maxim Mokin, et al.
Signal Transduction and Targeted Therapy|April 13, 2025
Meplazumab, a CD147 antibody, for severe COVID-19: a double-blind, randomized, placebo-controlled, phase 3 clinical trialHuijie Bian, Liang Chen, Zheng Zhang, et al.
Signal Transduction and Targeted Therapy|May 18, 2021
Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trialHuijie Bian, Zhao-Hui Zheng, Ding Wei, et al.
Pageof 72